IMARC Group’s report titled “Virus Filtration Market Report by Product (Consumables, Instruments, Services), Application (Biologicals, Medical Devices, Water Purification, Air Purification, and Others), End Use (Biopharmaceuticals and Biotechnology Companies, Contract Research Organizations, Academic Institutes and Research Laboratories, and Others), and Region 2023-2028“. The global virus filtration market size reached US$ 3.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 6.9 Billion by 2028, exhibiting a growth rate (CAGR) of 9.5% during 2023-2028.
Factors Affecting the Growth of the Global Virus Filtration Industry:
- Expanding Biopharmaceutical Industry:
The expansion of the biopharmaceutical industry is a significant factor driving the growth of the virus filtration market. This industry is experiencing rapid growth due to the increasing demand for therapeutic proteins and vaccines, particularly in the context of rising chronic diseases and pandemics. Virus filtration is a critical step in the production of biopharmaceutical products to ensure safety and regulatory compliance. The process removes viral contaminants, thereby ensuring the purity and efficacy of biopharmaceutical products. The stringent regulatory requirements for biopharmaceutical production, emphasizing product safety, further boost the demand for efficient virus filtration solutions. As the biopharmaceutical industry continues to expand globally, the need for advanced virus filtration technologies is expected to rise, propelling market growth.
- Technological Advancements:
Technological advancements in virus filtration methods are another key driver of this market. Modern filtration technologies have evolved to offer higher efficiency, reliability, and scalability, catering to the diverse needs of various end-users like pharmaceutical companies, research institutes, and healthcare providers. Innovations in filter materials, pore size, and filtration systems have enhanced the ability to effectively remove a wide range of viruses, including those of small size, from different products and samples. These advancements not only increase the effectiveness of viral clearance but also contribute to the streamlining of the manufacturing process. The continuous research and development in this field, aiming to address challenges such as high costs and process complexities, further fuel the growth of the virus filtration market.
- Increased Focus on Regulatory Compliance:
The heightened focus on regulatory compliance and safety standards in pharmaceutical and biotechnological product manufacturing is a crucial driver for the virus filtration market. Regulatory agencies worldwide, such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA), have implemented stringent guidelines for product safety, including mandatory virus filtration steps for certain product categories. These regulations ensure that therapeutic products are free from viral contaminants, thereby safeguarding public health. The increasing emphasis on these safety standards compels manufacturers to adopt robust virus filtration technologies, thus boosting market growth. Additionally, the rise in global health concerns and potential viral outbreaks has intensified the focus on ensuring the safety of medical products, further reinforcing the importance of virus filtration in the healthcare industry.
Leading Companies Operating in the Global Virus Filtration Industry:
- Asahi Kasei Medical Co. Ltd.
- Charles River Laboratories Inc.
- Clean Cells
- Danaher Corporation
- Merck KGaA
- Sartorius AG
- Thermo Fisher Scientific Inc.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/virus-filtration-market/requestsample
Virus Filtration Market Report Segmentation:
By Product:
- Consumables
- Kits and Reagents
- Others
- Instruments
- Filtration Systems
- Chromatography Systems
- Services
Consumables accounts for largest market share due to the recurring need for filtration consumables, such as membranes, cartridges, and cassettes.
By Application:
- Biologicals
- Vaccines and Therapeutics
- Blood and Blood Products
- Cellular and Gene Therapy Products
- Others
- Medical Devices
- Water Purification
- Air Purification
- Others
Biologicals holds for the largest market share due to due to the rising demand for biotherapeutic products.
By End Use:
- Biopharmaceuticals and Biotechnology Companies
- Contract Research Organizations
- Academic Institutes and Research Laboratories
- Others
Biopharmaceuticals and biotechnology companies holds the largest market share due to the escalating demand for biopharmaceuticals and the rapid growth of biotechnology companies.
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Virus Filtration Market Trends:
The growth of the biopharmaceutical industry, including the production of vaccines, monoclonal antibodies, and gene therapies, is driving the demand for virus filtration technologies to ensure product safety. Besides, the development and production of vaccines, including those for emerging infectious diseases, have led to increased adoption of virus filtration processes for viral clearance and purification. Moreover, the occurrence of novel viral outbreaks, such as the COVID-19 pandemic, highlights the need for robust virus filtration processes in biomanufacturing to prevent viral contamination.
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact Us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: [email protected]
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145 |United Kingdom: +44-753-713-2163
About The Author
